Literature DB >> 31603661

An Evidence Synthesis of Pharmaceuticals and Personal Care Products (PPCPs) in the Environment: Imbalances among Compounds, Sewage Treatment Techniques, and Ecosystem Types.

Michael F Meyer1, Stephen M Powers2, Stephanie E Hampton2.   

Abstract

Pharmaceuticals and personal care products (PPCPs) garner increasing attention globally for both their usefulness as indicators of human waste and their potency as emerging organic toxicants. Three decades of rapid increase in PPCP study combined with an increasing number of PPCPs on the global market have created an opportunity (1) to review trends in diversity of compounds, sewage treatment techniques (STTs), and ecosystems investigated as well as (2) to identify knowledge gaps in the literature. We conducted a quantitative evidence synthesis of 6517 abstracts from primary articles in the environmental PPCP literature by examining relative abundance of specific PPCP classes, STTs, and ecosystem types. Our results demonstrate that non-prescription drugs and antibiotics dominated PPCP abstracts, appearing in 51% and 39% of reviewed abstracts, respectively, in comparison to hormones (18%), prescription drugs (18%), fragrances (0.3%), and antioxidants (0.0%), which can all elicit physiological and ecological responses even at low concentrations. References to centralized STTs (e.g., activated sludge, 37%) were more frequent than decentralized STTs (e.g., septic, 2%), despite decentralized STTs being common and frequently high impact sources of sewage pollution worldwide. Freshwater lotic systems (63%) were more prevalent than freshwater lentic (24%) and terrestrial (20%) systems. This discrepancy is notable because the longer residence times of lentic and terrestrial systems may enable PPCPs to concentrate and thus increase risk of biological consequences. These results highlight distinct opportunities to address knowledge gaps in the environmental PPCP literature, including underrepresented compounds (e.g., fragrances), sewage treatment techniques (e.g., septic systems), and ecosystem types (e.g., lakes).

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31603661     DOI: 10.1021/acs.est.9b02966

Source DB:  PubMed          Journal:  Environ Sci Technol        ISSN: 0013-936X            Impact factor:   9.028


  6 in total

1.  Evaluation of the Correspondence between the Concentration of Antimicrobials Entering Sewage Treatment Plant Influent and the Predicted Concentration of Antimicrobials Using Annual Sales, Shipping, and Prescriptions Data.

Authors:  Takashi Azuma; Takashi Nakano; Ryuji Koizumi; Nobuaki Matsunaga; Norio Ohmagari; Tetsuya Hayashi
Journal:  Antibiotics (Basel)       Date:  2022-04-01

2.  A Generalized Physiologically Based Kinetic Model for Fish for Environmental Risk Assessment of Pharmaceuticals.

Authors:  Jiaqi Wang; Tom M Nolte; Stewart F Owen; Rémy Beaudouin; A Jan Hendriks; Ad M J Ragas
Journal:  Environ Sci Technol       Date:  2022-04-26       Impact factor: 11.357

3.  Inactivation of Bacteria and Residual Antimicrobials in Hospital Wastewater by Ozone Treatment.

Authors:  Takashi Azuma; Miwa Katagiri; Tsuyoshi Sekizuka; Makoto Kuroda; Manabu Watanabe
Journal:  Antibiotics (Basel)       Date:  2022-06-27

4.  Spatial and temporal variability of contaminants of emerging concern in a drinking water source.

Authors:  Rama Pulicharla; Francois Proulx; Sonja Behmel; Jean-B Sérodes; Manuel J Rodriguez
Journal:  RSC Adv       Date:  2022-07-21       Impact factor: 4.036

Review 5.  Occurrence, transformation, bioaccumulation, risk and analysis of pharmaceutical and personal care products from wastewater: a review.

Authors:  Uttpal Anand; Bashir Adelodun; Carlo Cabreros; Pankaj Kumar; S Suresh; Abhijit Dey; Florencio Ballesteros; Elza Bontempi
Journal:  Environ Chem Lett       Date:  2022-08-17       Impact factor: 13.615

6.  Evolutionary conservation of leptin effects on wound healing in vertebrates: Implications for veterinary medicine.

Authors:  Robyn E Reeve; Kyla Quale; Grace H Curtis; Erica J Crespi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-25       Impact factor: 6.055

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.